Chemopreventive and anticarcinogenic effects of Momordica charantia extract

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 2, 2010, Pages 371-375

  Agrawal, R C ^a   Beohar, Tripti ^a  

^a Jawaharlal Nehru Cancer Hospital & Research Centre Bhopal   (India)

Author keywords

Chromosomal aberrations; Micronucleus test; Momordica charantia; Skin anticarcinogenicity

Indexed keywords

EID: 78650686798     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agrawal RC, Kumar S (1998). Prevention of cyclophosphamide induced Micronucleus formation in mouse bone marrow by Indole-3-carbinol. Food and Chemical Toxicol, 36, 975-7.
2. Agrawal RC, Kumar S (1999). Prevention of chromosomal aberrations in mouse bone marrow by Indole-3-carbinol. Toxicology Letters, 106, 137-41.
3. Agrawal RC, Jain R, Raja W, et al (2009). Anticarcinogenic effects of Solanum lycopersicum fruit extract on Swiss albino and C57 BL mice. Asian Pac J Cancer Prev, 10, 379-82.
4. Berenbrum I (1975). Sequential aspects of chemical carcinogenesis in skin Cancer: A comprehensive treatise, Plenum press. New York, 1, 323-4.
5. Bertram JS, Kolonel LN, Meyskens FL (1987). Rationale and strategies for chemoprevention of cancer in humans. Cancer Res, 47, 3012-31.
6. Boone CW, Kelloff CJ, Malone WE (1990). Identification of candidate chemopreventive agents and their evaluation in animals models and human clinical trials: a review. Cancer Res, 50, 2-9.
7. Chession A, Collins A (1997). Assessment of the role of diet in cancer prevention. Cancer Lett, 237-41.
8. Grover JK, Yadav SP (2004). Pharmacological actions and potential uses of Momordica charantia: a review. 93, 123-32.
9. Jilka C, Strifler B, Fortner GW, et al (1983). In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res, 43, 5151-5.
10. Miyahara YH Okabe and Yamuchi T (1981). Studies on the constituents of Momordica charantia L. II. Isolation and characterization of the constituents of minor seed glycosides, Momordicosides, C, D and E. Chem Phar Bull, 29, 1561-6.
11. Perchellet JP, Perchellet EM (1989)Antioxidant and multistage carcinogenesis in mouse skin. Free Rad Biol. Med, 7, 377.
12. Preston JR, Brian J Dean, Sheila Galloway, et al (1987). Mammalian in vivo cytogenetic assays, Analysis of chromosomal aberrations in mouse bone marrow cells. Mut Res, 189, 157-65.
13. Rao KVK, Schwartz SA, Nair HK (2004). Plant derived products as a source of cellular growth inhibitory phytochemicals on PC-3M, DU-145 and LNCaP prostate cancer cell lines. Current Sci, 87, 1585-8.
14. Seham Abd El Sattar El Batran, Souad E, El-Gengaihi and Osama A. El Shabrawy (2006). Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacology, 108, 236-42.
15. Singh, Anjali, Satya Prakash Singh and Ramesh Bamezai (1998) Postnatal efficacy of Momordica charantia peel, pulp, seed and whole fruit extract in the detoxication pathway of suckling neonates and lactating mice. Cancer Letters, 122, 121-6.
16. Singh, Anjali Satya Prakash Singh and Ramesh Bamezai Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papilliomagenesis. Available online 30 March 1998. (4) Toxicology Letters, 1998.
17. Schmid W (1975). The micronucleus test, Mutation Res, 31, 9-15.
18. Tennekoon KH, Jeevathayaaparan S, Angunwala P, et al (2004). Effect of Momordica charantia on key hepatic enzyme. J Ethanopharmacology, 99, 123-32.